• H. FiedlerEmail author
Part of the Springer Reference Medizin book series (SRM)


  1. Fagan AM, Shaw LM, Xiong C et al (2011) Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology. Arch Neurol 68:1137–1144PubMedPubMedCentralCrossRefGoogle Scholar
  2. Lahiri DK, Maloney B (2010) Beyond the signaling effect role of amyloid-β42 on the processing of APP, and its clinical implications. Exp Neurol 225:51–54PubMedPubMedCentralCrossRefGoogle Scholar
  3. Nussbaum JM, Seward ME, Bloom GS (2013) Alzheimer disease. A tale of two prions. Prion 7:14–19PubMedPubMedCentralCrossRefGoogle Scholar
  4. Rösler N, Wichart I, Jellinger KA (2002) Aktuelle klinisch-neurochemische Diagnostik der Alzheimer-Krankheit. J Lab Med 26:139–148Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2019

Authors and Affiliations

  1. 1.ErfurtDeutschland

Personalised recommendations